{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T14:49:46Z","timestamp":1782226186824,"version":"3.54.5"},"reference-count":26,"publisher":"Galenos Yayinevi","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["tjtcs"],"DOI":"10.4274\/tjtcs.2025.28900","type":"journal-article","created":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T13:45:02Z","timestamp":1772027102000},"source":"Crossref","is-referenced-by-count":0,"title":["Prognostic effect of systemic inflammation in patients undergoing cytoreductive surgery and hyperthermic intrathoracic chemotherapy"],"prefix":"10.4274","author":[{"given":"Ahmet Kayahan","family":"Tekneci","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hasan","family":"Yavuz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gizem","family":"Ke\u00e7eci \u00d6zg\u00fcr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tevfik \u0130lker","family":"Ak\u00e7am","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ay\u015fe G\u00fcl","family":"Erg\u00f6n\u00fcl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kutsal","family":"Turhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alpaslan","family":"\u00c7akan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ufuk","family":"\u00c7a\u011f\u0131r\u0131c\u0131","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2811","published-online":{"date-parts":[[2026,2,25]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","unstructured":"1. Okabe K. Intraoperative intracavitary hyperthermic chemotherapy for malignant pleural meso-thelioma. Ann Transl Med. 2017;5:233. doi: 10.21037\/atm.2017.03.78.","DOI":"10.21037\/atm.2017.03.78"},{"key":"ref1","doi-asserted-by":"publisher","unstructured":"2. Opitz I, Sigrist B, Hillinger S, Lardinois D, Stahel R, Weder W, et al. Taurolidine and povidone-iodine induce different types of cell death in malignant pleural mesothelioma. Lung Cancer. 2007;56:327-36. doi: 10.1016\/j.lungcan.2007.01.024.","DOI":"10.1016\/j.lungcan.2007.01.024"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"3. Janssen-Heijnen ML, Damhuis RA, Klinkhamer PJ, Schipper RM, Coebergh JW. Increased but low incidence and poor survival of malignant mesothelioma in the southeastern part of the Netherlands since 1970: a population-based study. Eur J Cancer Prev. 1999;8:311-4. doi: 10.1097\/00008469-199908000-00007.","DOI":"10.1097\/00008469-199908000-00007"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"4. Boylan AM. Mesothelioma: new concepts in diagnosis and management. Curr Opin Pulm Med. 2000;6:157-63. doi: 10.1097\/00063198-200003000-00013.","DOI":"10.1097\/00063198-200003000-00013"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"5. Ried M, Potzger T, Braune N, Neu R, Zausig Y, Schalke B, et al. Cytoreductive surgery and hyper-thermic intrathoracic chemotherapy perfusion for malignant pleural tumours: perioperative management and clinical experience. Eur J Cardiothorac Surg. 2013;43:801-7. doi: 10.1093\/ejcts\/ezs418.","DOI":"10.1093\/ejcts\/ezs418"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"6. Carpagnano GE, Palladino GP, Lacedonia D, Koutelou A, Orlando S, Foschino-Barbaro MP. Neutrophilic airways inflammation in lung cancer: the role of exhaled LTB-4 and IL-8. BMC Cancer. 2011;11:226. doi: 10.1186\/1471-2407-11-226.","DOI":"10.1186\/1471-2407-11-226"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"7. Ebin\u00e7 S, Oru\u00e7 Z, Kalkan Z, Karhan O, Urak\u00e7\u0131 Z, K\u00fc\u00e7\u00fck\u00f6ner M, et al. Prognostic factors and the prognostic role of inflammation indices in malignant pleural mesothelioma. Turk Gogus Kalp Damar Cerrahisi Derg. 2023;31:105-15. doi: 10.5606\/tgkdc.dergisi.2023.23365.","DOI":"10.5606\/tgkdc.dergisi.2023.23365"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"8. Abakay O, Tanrikulu AC, Palanci Y, Abakay A. The value of inflammatory parameters in the prognosis of malignant mesothelioma. J Int Med Res. 2014;42:554-65. doi: 10.1177\/0300060513504163..","DOI":"10.1177\/0300060513504163"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"9. Chen N, Liu S, Huang L, Li W, Yang W, Cong T, et al. Prognostic significance of neutrophil-to-lymphocyte ratio in patients with malignant pleural mesothelioma: a meta-analysis. Oncotar-get. 2017;8:57460-9. doi: 10.18632\/oncotarget.15404.","DOI":"10.18632\/oncotarget.15404"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"10. Wolf AS, Eisele M, Giroux DJ, Gill R, Nowak AK, Bille A, et al. The international association for the study of lung cancer pleural mesothelioma staging project: expanded database to inform revisions in the ninth edition of the TNM classification of pleural mesothelioma. J Thorac On-col. 2024;19:1242-52. doi: 10.1016\/j.jtho.2024.01.018.","DOI":"10.1016\/j.jtho.2024.01.018"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"11. Gutierrez-Sainz L, Cruz P, Martinez-Recio S, Higuera O, Esteban-Rodriguez MI, Arias-Lotto F, et al. Malignant pleural mesothelioma: clinical experience and prognostic value of derived neu-trophil-to-lymphocyte ratio and PD-L1 expression. Clin Transl Oncol. 2021;23:2030-5. doi: 10.1007\/s12094-021-02605-w.","DOI":"10.1007\/s12094-021-02605-w"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"12. Zhao H, Chen X, Zhang W, Cheng D, Lu Y, Wang C, et al. Pan-immune-inflammation value is associated with the clinical stage of colorectal cancer. Front Surg. 2022;9:996844. doi: 10.3389\/fsurg.2022.996844.","DOI":"10.3389\/fsurg.2022.996844"},{"key":"ref12","unstructured":"13. Mutlu E, Inanc M. Prognostic significance of inflammation scores in malignant mesothelioma. Eur Rev Med Pharmacol Sci. 2024;28:2340-50. doi: 10.26355\/eurrev_202403_35741."},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"14. Guthrie GJ, Roxburgh CS, Farhan-Alanie OM, Horgan PG, McMillan DC. Comparison of the prognostic value of longitudinal measurements of systemic inflammation in patients undergo-ing curative resection of colorectal cancer. Br J Cancer. 2013;109:24-8. doi: 10.1038\/bjc.2013.330.","DOI":"10.1038\/bjc.2013.330"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"15. Oh BS, Jang JW, Kwon JH, You CR, Chung KW, Kay CS, et al. Prognostic value of C-reactive pro-tein and neutrophil-to-lymphocyte ratio in patients with hepatocellular carcinoma. BMC Can-cer. 2013;13:78. doi: 10.1186\/1471-2407-13-78.","DOI":"10.1186\/1471-2407-13-78"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"16. Gu X, Gao X, Li X, Qi X, Ma M, Qin S, et al. Prognostic significance of neutrophil-to-lymphocyte ratio in prostate cancer: evidence from 16,266 patients. Sci Rep. 2016;6:22089. doi: 10.1038\/srep22089.","DOI":"10.1038\/srep22089"},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"17. Lohinai Z, Bonanno L, Aksarin A, Pavan A, Megyesfalvi Z, Santa B, et al. Neutrophil-lymphocyte ratio is prognostic in early stage resected small-cell lung cancer. PeerJ. 2019;7:e7232. doi: 10.7717\/peerj.7232.","DOI":"10.7717\/peerj.7232"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"18. Takahashi Y, Horio H, Hato T, Harada M, Matsutani N, Morita S, et al. Prognostic significance of preoperative neutrophil-lymphocyte ratios in patients with stage I non-small cell lung cancer af-ter complete resection. Ann Surg Oncol. 2015;22(Suppl 3):S1324-31. doi: 10.1245\/s10434-015-4735-5.","DOI":"10.1245\/s10434-015-4735-5"},{"key":"ref18","doi-asserted-by":"publisher","unstructured":"19. Mei Z, Shi L, Wang B, Yang J, Xiao Z, Du P, et al. Prognostic role of pretreatment blood neutro-phil-to-lymphocyte ratio in advanced cancer survivors: a systematic review and meta-analysis of 66 cohort studies. Cancer Treat Rev. 2017;58:1-13. doi: 10.1016\/j.ctrv.2017.05.005.","DOI":"10.1016\/j.ctrv.2017.05.005"},{"key":"ref19","doi-asserted-by":"publisher","unstructured":"20. Luzzi L, Franchi F, Dapoto A, Ghisalberti M, Corzani R, Marrelli D, et al. Hyperthermic intratho-racic chemotherapy after extended pleurectomy and decortication for malignant pleura meso-thelioma: an observational study on outcome and microcirculatory changes. J Thorac Dis. 2018;10(Suppl 2):S228-36. doi: 10.21037\/jtd.2018.01.10.","DOI":"10.21037\/jtd.2018.01.10"},{"key":"ref20","doi-asserted-by":"publisher","unstructured":"21. Cihan YB, Ozturk A, Mutlu H. Relationship between prognosis and neutrophil: lymphocyte and platelet:lymphocyte ratios in patients with malignant pleural mesotheliomas. Asian Pac J Can-cer Prev. 2014;15:2061-7. doi: 10.7314\/apjcp.2014.15.5.2061.","DOI":"10.7314\/APJCP.2014.15.5.2061"},{"key":"ref21","doi-asserted-by":"publisher","unstructured":"22. Pinato DJ, Mauri FA, Ramakrishnan R, Wahab L, Lloyd T, Sharma R. Inflammation-based prog-nostic indices in malignant pleural mesothelioma. J Thorac Oncol. 2012;7:587-94. doi: 10.1097\/JTO.0b013e31823f45c1.","DOI":"10.1097\/JTO.0b013e31823f45c1"},{"key":"ref22","doi-asserted-by":"publisher","unstructured":"23. Fournel L, Charrier T, Huriet M, Iaffaldano A, Lupo A, Damotte D, et al. Prognostic impact of in-flammation in malignant pleural mesothelioma: a large-scale analysis of consecutive patients. Lung Cancer. 2022;166:221-7. doi: 10.1016\/j.lungcan.2022.03.014.","DOI":"10.1016\/j.lungcan.2022.03.014"},{"key":"ref23","doi-asserted-by":"publisher","unstructured":"24. Yamagishi T, Fujimoto N, Nishi H, Miyamoto Y, Hara N, Asano M, et al. Prognostic significance of the lymphocyte-to-monocyte ratio in patients with malignant pleural mesothelioma. Lung Cancer. 2015;90:111-7. doi: 10.1016\/j.lungcan.2015.07.014.","DOI":"10.1016\/j.lungcan.2015.07.014"},{"key":"ref24","doi-asserted-by":"publisher","unstructured":"25. Lin F, Zhang LP, Xie SY, Huang HY, Chen XY, Jiang TC, et al. Pan-immune-inflammation value: a new prognostic index in operative breast cancer. Front Oncol. 2022;12:830138. doi: 10.3389\/fonc.2022.830138.","DOI":"10.3389\/fonc.2022.830138"},{"key":"ref25","doi-asserted-by":"publisher","unstructured":"26. Guven DC, Sahin TK, Erul E, Kilickap S, Gambichler T, Aksoy S. The association between the pan-immune-inflammation value and cancer prognosis: a systematic review and meta-analysis. Cancers (Basel). 2022;14:2675. doi: 10.3390\/cancers14112675.","DOI":"10.3390\/cancers14112675"}],"container-title":["Turkish Journal of Thoracic and Cardiovascular Surgery"],"original-title":[],"deposited":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T13:53:07Z","timestamp":1782222787000},"score":1,"resource":{"primary":{"URL":"https:\/\/tjtcvs.org\/articles\/prognostic-effect-of-systemic-inflammation-in-patients-undergoing-cytoreductive-surgery-and-hyperthermic-intrathoracic-chemotherapy\/doi\/tjtcs.2025.28900"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,25]]},"references-count":26,"URL":"https:\/\/doi.org\/10.4274\/tjtcs.2025.28900","relation":{},"ISSN":["1301-5680","1301-5680"],"issn-type":[{"value":"1301-5680","type":"print"},{"value":"1301-5680","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,25]]}}}